Applications
Applications
Schedule I of Form 990 lists the grants made, not how to apply, so this return does not say whether Pediatric Cancer Research Foundation accepts applications.
From its returns
What it gave
Pediatric Cancer Research Foundation paid $1,695,918 in grants in the year ending June 2025.
| Year ending | Grants paid | Grants listed |
|---|---|---|
| June 2025 | $1,695,918 | 15 |
| June 2024 | $914,813 | 14 |
From Schedule I of its Form 990 returns for the years ending June 2024 to June 2025.
Focus and places
What it funds, and where
From the 29 grants listed on its returns for the years ending June 2024 to June 2025. A grant counts toward a focus only when it is linked to the charity that received it: 10 of 29 are.
Focus, by share of linked grant dollars
Where it gave, by number of grants
From Schedule I of its Form 990 returns for the years ending June 2024 to June 2025.
Grants
Recent grants to organizations
The largest grants on its latest returns, as filed. A name links to the charity’s profile when the match is certain.
| Recipient | Year ending | Amount | Purpose |
|---|---|---|---|
| NEW YORK MEDICAL COLLEGEValhalla, New York | June 2025 | $550,000 | PEDIATRIC CANCER RESEARCH FOUNDATION LABORATORY AT NEW YORK MEDICAL COLLEGE |
| The V FoundationCary, North Carolina | June 2025 | $204,000 | CANCER RESEARCH |
| MEMORIAL SLOAN KETTERINGNew York, New York | June 2025 | $150,000 | TOWARDS CURATIVE EPIGENETIC THERAPIES OF REFRACTORY PEDIATRIC SARCOMAS |
| City of Hope National Medical CenterDuarte, California | June 2025 | $100,000 | SINGLE-CELL DISSECTING OF HIGH-RISK B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA |
| Dana-Farber Cancer InstituteBoston, Massachusetts | June 2025 | $100,000 | ADVANCING LIQUID BIOPSIES TO THE CLINIC FOR PATIENTS WITH EWING SARCOMA |
| STANFORDPalo Alto, California | June 2025 | $100,000 | TARGETING MITOCHONDRIAL PATHWAYS IN PEDIATRIC AML |
| JOHNS HOPKINSBaltimore, Maryland | June 2025 | $100,000 | TARGETING SHP2 AS A THERAPEUTIC STRATEGY IN FUSION-NEGATIVE RHABDOMYOSARCOMA |
| UNIVERSITY OF CALIFORNIA SAN FRANCISCOSan Francisco, California | June 2025 | $45,000 | A RISK STRATIFIED CLINICAL TRIAL FOR PATIENTS WITH NEWLY DIAGNOSED JUVENILE MYELOMONOCYTIC LEUKEMIA |
| CHILDREN'S HOSPITAL LOS ANGELESLos Angeles, California | June 2025 | $37,500 | PRECLINIAL STUDY TO TRANSLATE THERAPY USING DNA HYPOMETHYLATING AGENTS FOR PEDIATRIC HIGH GRADE GLIOMAS |
| CASE WESTERNClevenland, Ohio | June 2025 | $37,500 | USE OF MR FINGERPRINTING FOR DETERMINING RESPONSE TO IMMUNOTHERAPY IN PEDIATRIC BRAIN TUMORS |
| CHILDREN'S HOSPITAL LOS ANGELESLos Angeles, California | June 2025 | $32,000 | RESEARCH INTO MULTIDISCIPLINARY APPROACH TO SIGNIFICANTLY AND POSITIVELY IMPROVE THE QUALITY OF LIFE OF AND QUALITY OF CARE FOR CHILDREN AND YOUNG PEOPLE WITH CANCER |
| Hope for Henry FoundationWashington, District of Columbia | June 2025 | $30,000 | REWARDING PEDIATRIC PATIENTS AND ELEVATING THEIR CARE |
| INDIANA UNIVERSITYBloomington, Indiana | June 2025 | $27,000 | DECODING METABOLIC DEPENDENCIES OF MPNSTS AND ITS MICROENVIRONMENT |
| Ronald McDonald House Charities of Southern CaliforniaLos Angeles, California | June 2025 | $25,000 | WILDFIRE RECOVERY FUNDING FOR FAMILIES OF CANCER PATIENTS AT THE LOS ANGELES RONALD MCDONALD HOUSE |
| Live for Liv FoundationWestford, Massachusetts | June 2025 | $8,000 | SUPPORTS CHILDREN AND FAMILIES DEALING WITH SERIOUS CONDITIONS |
| NEW YORK MEDICAL COLLEGEValhalla, New York | June 2024 | $275,000 | PEDIATRIC CANCER RESEARCH FOUNDATION LABORATORY AT NEW YORK MEDICAL COLLEGE |
| MEMORIAL SLOAN KETTERINGNew York, New York | June 2024 | $75,000 | TOWARDS CURATIVE EPIGENETIC THERAPIES OF REFRACTORY PEDIATRIC SARCOMAS |
| City of Hope National Medical CenterDuarte, California | June 2024 | $50,000 | SINGLE-CELL DISSECTING OF HIGH-RISK B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA |
| Dana-Farber Cancer InstituteBoston, Massachusetts | June 2024 | $50,000 | PROSPECTIVE VALIDATION OF A PROGNOSTIC LIQUID BIOPSY APPROACH FOR PEDIATRIC EWING SARCOMA |
| STANFORD UNIVERSITYPalo Alto, California | June 2024 | $50,000 | TARGETING MITOCHONDRIAL PATHWAYS IN PEDIATRIC AML |
| JOHNS HOPKINS UNIVERSITYBaltimore, Maryland | June 2024 | $50,000 | TARGETING SHP2 AS A THERAPEUTIC STRATEGY IN FUSION-NEGATIVE RHABDOMYOSARCOMA |
| Hope for Henry FoundationWashington, District of Columbia | June 2024 | $49,563 | REWARDING PEDIATRIC PATIENTS AND ELEVATING THEIR CARE |
| UCSFSan Francisco, California | June 2024 | $40,000 | TACL2020-004: A RISK STRATIFIED CLINICAL TRIAL FOR PATIENTS WITH NEWLY DIAGNOSED JUVENILE MYELOMONOCYTIC LEUKEMIA |
| CHILDREN'S HOSPITAL OF LOS ANGELESLos Angeles, California | June 2024 | $37,500 | PRECLINIAL STUDY TO TRANSLATE THERAPY USING DNA HYPOMETHYLATING AGENTS FOR PEDIATRIC HIGH GRADE GLIOMAS |
| CASE WESTERNClevenland, Ohio | June 2024 | $37,500 | USE OF MR FINGERPRINTING FOR DETERMINING RESPONSE TO IMMUNOTHERAPY IN PEDIATRIC BRAIN TUMORS |
Showing 25 of the 29 grants listed on its returns for the years ending June 2024 to June 2025. From Schedule I of its Form 990 returns for the years ending June 2024 to June 2025.